Pivotal U.S. Clinical Validation of AI-COA® for Depression and Anxiety

Part of paid clinical trials in Houston, Texas.

Sponsor
Deliberate Solutions Inc.
Study ID
NCT07279038
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Anxiety Disorders
  • Depression Disorders

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Study Details

This study is a large-scale pivotal clinical validation of the AI-COA® software device. The purpose is to confirm the tool's accuracy and performance across a demographically diverse population of adults with Major Depressive Disorder (MDD), ensuring it functions fairly and reliably across different subgroups.

Key Dates

Start date
Mar 1, 2027
Status verified
Dec 2025
Primary completion
Aug 28, 2029
Completion
Aug 28, 2029

Study Design

Enrollment
650 participants (estimated)

Primary Outcome Measure

HAM-D ICC [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Baylor College of MedicineHoustonTexas77030-

Find similar trials in Houston, TX

By research site
Baylor College of Medicine· Houston, TX

Related Studies